Stan Berenshteyn Analyst Performance

Equity Research Analyst, Digital Health at Wells Fargo & Company

Stan Berenshteyn is a stock analyst at Wells Fargo & Company focused in the medical sector, covering 9 publicly traded companies. Over the past year, Stan Berenshteyn has issued 15 stock ratings, including buy and hold recommendations. While full access to Stan Berenshteyn's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Stan Berenshteyn's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 19 Last 3 Years
Buy Recommendations: 55.56% 10 Buy Ratings
Companies Covered: 9 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	55.6%	10 ratings
Hold	44.4%	8 ratings
Sell	0.0%	0 ratings

Out of 18 total stock ratings issued by Stan Berenshteyn at Wells Fargo & Company, the majority (55.6%) have been Buy recommendations, followed by 44.4% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	66.7% of companies on NASDAQ	6 companies
NYSE	33.3% of companies on NYSE	3 companies

Stan Berenshteyn, an analyst at Wells Fargo & Company, currently covers 9 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 8 companies	88.9%
	Business Services 1 company	11.1%

Stan Berenshteyn of Wells Fargo & Company specializes in stock coverage within the Medical sector, with additional focus on Business Services companies.

Coverage Industries

Industry	Percentage
MEDICAL INFO SYS 4 companies	44.4%
MEDICAL SERVICES 3 companies	33.3%
CUSTOM COMPUTER PROGRAMMING SERVICES 1 company	11.1%
BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED 1 company	11.1%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
VEEV Veeva Systems	8/26/2025	Boost Price Target	$285.54	$326.00	Overweight
HCAT Health Catalyst	8/11/2025	Lower Price Target	$2.57	$6.00	Overweight
AMWL American Well	8/7/2025	Lower Price Target	$7.50	$12.00	Overweight
DOCS Doximity	8/4/2025	Boost Price Target	$58.54	$62.00	Equal Weight
OMCL Omnicell	7/21/2025	Boost Price Target	$27.82	$40.00	Overweight
VEEV Veeva Systems	5/29/2025	Boost Price Target	$281.19	$300.00	Overweight
OMCL Omnicell	5/14/2025	Upgrade	$28.00	$35.00	Overweight
TDOC Teladoc Health	5/8/2025	Lower Price Target	$6.90	$8.00	Equal Weight
OMCL Omnicell	5/7/2025	Lower Price Target	$25.42	$31.00	Equal Weight
GDRX GoodRx	4/29/2025	Lower Price Target	$4.60	$7.00	Overweight
OMCL Omnicell	4/17/2025	Lower Price Target	$30.17	$38.00	Equal Weight
GDRX GoodRx	2/28/2025	Lower Price Target	$4.85	$8.00	Overweight
HQY HealthEquity	2/26/2025	Boost Price Target	$107.45	$125.00	Overweight
HCAT Health Catalyst	1/21/2025	Lower Price Target	$5.88	$10.00	Overweight
OMCL Omnicell	1/13/2025	Lower Price Target	$42.25	$40.00	Equal Weight

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.